{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:25:36Z","timestamp":1761863136402},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1097\/mbc.0b013e3283573a42","type":"journal-article","created":{"date-parts":[[2012,8,10]],"date-time":"2012-08-10T07:03:48Z","timestamp":1344582228000},"page":"640-648","source":"Crossref","is-referenced-by-count":16,"title":["Soluble CD163 in young sickle cell disease patients and their trait siblings"],"prefix":"10.1097","volume":"23","author":[{"given":"Azza Abdel Gawad","family":"Tantawy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amira Abdel Moneam","family":"Adly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman Abdel Rahman","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-13-20210203","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","article-title":"Sickle cell disease.","volume":"376","author":"Rees","year":"2010","journal-title":"Lancet"},{"key":"R2-13-20210203","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/ncpendmet0702","article-title":"Therapy insight: metabolic and endocrine disorders in sickle cell disease.","volume":"4","author":"Smiley","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"R3-13-20210203","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.hoc.2005.07.007","article-title":"Pulmonary hypertension in sickle cell disease: mechanisms, diagnosis, and management.","volume":"19","author":"Castro","year":"2005","journal-title":"Hematol Oncol Clin North Am"},{"key":"R4-13-20210203","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.3324\/haematol.11576","article-title":"Tricuspid regurgitant jet velocity is associated with hemolysis in children and young adults with sickle cell disease evaluated for pulmonary hypertension.","volume":"92","author":"Liem","year":"2007","journal-title":"Haematologica"},{"key":"R5-13-20210203","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4103\/0974-6013.44873","article-title":"Pulmonary hypertension in sickle cell disease.","volume":"1","author":"Machado","year":"2009","journal-title":"PVRI Rev"},{"key":"R6-13-20210203","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1056\/NEJMp038250","article-title":"Pulmonary hypertension in sickle cell disease.","volume":"350","author":"Vichinsky","year":"2004","journal-title":"N Engl J Med"},{"key":"R7-13-20210203","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S0140-6736(04)17192-4","article-title":"Sickle-cell disease.","volume":"364","author":"Stuart","year":"2004","journal-title":"Lancet"},{"key":"R8-13-20210203","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5001\/omj.2010.2","article-title":"A review of clinical profile in sickle cell traits.","volume":"25","author":"John","year":"2010","journal-title":"Oman Med J"},{"key":"R9-13-20210203","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1123\/jsr.16.3.197","article-title":"Sickle cell trait.","volume":"16","author":"Eichner","year":"2007","journal-title":"J Sport Rehabil"},{"key":"R10-13-20210203","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1128\/JVI.02093-09","article-title":"Identification of the CD163 protein domains involved in infection of the porcine reproductive and respiratory syndrome virus.","volume":"84","author":"Van Gorp","year":"2010","journal-title":"J Virol"},{"key":"R11-13-20210203","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/35051594","article-title":"Identification of the haemoglobin scavenger receptor.","volume":"409","author":"Kristiansen","year":"2001","journal-title":"Nature"},{"key":"R12-13-20210203","doi-asserted-by":"crossref","first-page":"5223","DOI":"10.1182\/blood-2006-08-036467","article-title":"The macrophage CD163 surface glycoprotein is an erythroblast adhesion receptor.","volume":"109","author":"Fabriek","year":"2007","journal-title":"Blood"},{"key":"R13-13-20210203","doi-asserted-by":"crossref","first-page":"8183","DOI":"10.4049\/jimmunol.178.12.8183","article-title":"A previously unrecognized protein-protein interaction between TWEAK and CD163: potential biological implications.","volume":"178","author":"Bover","year":"2007","journal-title":"J Immunol"},{"key":"R14-13-20210203","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1182\/blood-2008-07-167064","article-title":"The macrophage scavenger receptor CD163 functions as an innate immune sensor for bacteria.","volume":"113","author":"Fabriek","year":"2009","journal-title":"Blood"},{"key":"R15-13-20210203","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1046\/j.1365-2249.2002.01963.x","article-title":"Elevated levels of soluble CD163 in sera and fluids from rheumatoid arthritis patients and inhibition of the shedding of CD163 by TIMP-3.","volume":"130","author":"Matsushita","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"R16-13-20210203","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.imbio.2009.05.003","article-title":"Soluble macrophage-derived CD163: a homogenous ectodomain protein with a dissociable haptoglobin-hemoglobin binding.","volume":"215","author":"Moller","year":"2010","journal-title":"Immunobiology"},{"key":"R17-13-20210203","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/003655102762377466","article-title":"Soluble CD163: a marker molecule for monocytemacrophage activity in disease.","volume":"237","author":"Moller","year":"2002","journal-title":"Scand J Clin Lab Invest Suppl"},{"key":"R18-13-20210203","doi-asserted-by":"crossref","first-page":"57","DOI":"10.14712\/18059694.2016.105","article-title":"Scavenger receptor CD163 and its biological functions.","volume":"52","author":"Onofre","year":"2009","journal-title":"Acta Medica (Hradec Kralove)"},{"key":"R19-13-20210203","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/nm1202-799","article-title":"3rd, Schechter AN, et al. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease.","volume":"8","author":"Reiter","year":"2002","journal-title":"Nat Med"},{"key":"R20-13-20210203","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1182\/blood-2002-10-3313","article-title":"Transgenic sickle mice have vascular inflammation.","volume":"101","author":"Belcher","year":"2003","journal-title":"Blood"},{"key":"R21-13-20210203","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2141.2011.08580.x","article-title":"Soluble CD163 levels in children with sickle cell disease.","volume":"153","author":"Moller","year":"2011","journal-title":"Br J Haematol"},{"key":"R22-13-20210203","doi-asserted-by":"crossref","first-page":"e2010025","DOI":"10.4084\/mjhid.2010.025","article-title":"Descriptive epidemiology of hemophilia and other coagulation disorders in mansoura, egypt: retrospective analysis.","volume":"2","author":"Tonbary","year":"2010","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"R23-13-20210203","first-page":"1013","article-title":"Sickle cell disease in childhood: Part I. Laboratory diagnosis, pathophysiology and health maintenance.","volume":"62","author":"Wethers","year":"2000","journal-title":"Am Fam Physician"},{"key":"R25-13-20210203","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1182\/blood.V84.2.643.643","article-title":"The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease.","volume":"84","author":"Castro","year":"1994","journal-title":"Blood"},{"key":"R26-13-20210203","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1182\/blood.V96.7.2451","article-title":"Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion.","volume":"96","author":"Belcher","year":"2000","journal-title":"Blood"},{"key":"R27-13-20210203","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1189\/jlb.1205756","article-title":"Pivotal advance: Activation of cell surface Toll-like receptors causes shedding of the hemoglobin scavenger receptor CD163.","volume":"80","author":"Weaver","year":"2006","journal-title":"J Leukoc Biol"},{"key":"R28-13-20210203","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1189\/jlb.0706428","article-title":"Up-regulation of human monocyte CD163 upon activation of cell-surface Toll-like receptors.","volume":"81","author":"Weaver","year":"2007","journal-title":"J Leukoc Biol"},{"key":"R29-13-20210203","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3233\/CH-2008-1078","article-title":"Blood rheology abnormalities and vascular cell adhesion mechanisms in sickle cell trait carriers during exercise.","volume":"39","author":"Connes","year":"2008","journal-title":"Clin Hemorheol Microcirc"},{"key":"R30-13-20210203","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/ajh.10021","article-title":"Coagulation changes in individuals with sickle cell trait.","volume":"69","author":"Westerman","year":"2002","journal-title":"Am J Hematol"},{"key":"R31-13-20210203","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM199505183322001","article-title":"Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia.","volume":"332","author":"Charache","year":"1995","journal-title":"N Engl J Med"},{"key":"R32-13-20210203","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1001\/jama.289.13.1645","article-title":"Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment.","volume":"289","author":"Steinberg","year":"2003","journal-title":"JAMA"},{"key":"R33-13-20210203","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1182\/asheducation.V2000.1.2.2","article-title":"New views of sickle cell disease pathophysiology and treatment.","volume":"2000","author":"Rosse","year":"2000","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R34-13-20210203","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMra0804411","article-title":"Pulmonary complications of sickle cell disease.","volume":"359","author":"Gladwin","year":"2008","journal-title":"N Engl J Med"},{"key":"R35-13-20210203","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1056\/NEJMoa035477","article-title":"Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.","volume":"350","author":"Gladwin","year":"2004","journal-title":"N Engl J Med"},{"key":"R36-13-20210203","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3324\/haematol.11763","article-title":"Coagulation activation and inflammation in sickle cell disease-associated pulmonary hypertension.","volume":"93","author":"Ataga","year":"2008","journal-title":"Haematologica"},{"key":"R37-13-20210203","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00246-007-9018-x","article-title":"Pulmonary hypertension in children and adolescents with sickle cell disease.","volume":"29","author":"Onyekwere","year":"2008","journal-title":"Pediatr Cardiol"},{"key":"R38-13-20210203","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/ajh.20642","article-title":"6th, Little J, Butman JA, et al. Cerebrovascular disease associated with sickle cell pulmonary hypertension.","volume":"81","author":"Kato","year":"2006","journal-title":"Am J Hematol"},{"key":"R39-13-20210203","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.hoc.2005.08.002","article-title":"Sickle cell vaso-occlusion.","volume":"19","author":"Chiang","year":"2005","journal-title":"Hematol Oncol Clin North Am"},{"key":"R40-13-20210203","doi-asserted-by":"crossref","first-page":"67","DOI":"10.21307\/immunohematology-2019-234","article-title":"Sickle cell disease: a review.","volume":"25","author":"Roseff","year":"2009","journal-title":"Immunohematology"},{"key":"R41-13-20210203","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00277-004-1002-4","article-title":"Cardiovascular effects of splenomegaly and splenectomy in beta-thalassemia.","volume":"84","author":"Aessopos","year":"2005","journal-title":"Ann Hematol"},{"key":"R42-13-20210203","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF02983382","article-title":"Pulmonary arterial hypertension in previously splenectomized patients with beta-thalassemic disorders.","volume":"78","author":"Atichartakarn","year":"2003","journal-title":"Int J Hematol"},{"key":"R43-13-20210203","doi-asserted-by":"crossref","first-page":"465a","DOI":"10.1182\/blood.V104.11.1671.1671","article-title":"Plasma free HB is related to red cell derived vesicle numbers in sickle cell anemia and thalassemia intermedia: Implications for nitric oxide (NO) scavenging and pulmonary hypertension.","volume":"104","author":"Westerman","year":"2004","journal-title":"Blood"},{"key":"R44-13-20210203","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1172\/JCI26857","article-title":"Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice.","volume":"116","author":"Belcher","year":"2006","journal-title":"J Clin Invest"},{"key":"R45-13-20210203","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJM199403173301101","article-title":"High-dose intravenous methylprednisolone therapy for pain in children and adolescents with sickle cell disease.","volume":"330","author":"Griffin","year":"1994","journal-title":"N Engl J Med"}],"container-title":["Blood Coagulation & Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00001721-201210000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T03:50:28Z","timestamp":1643169028000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001721-201210000-00013"}},"subtitle":["a biomarker for pulmonary hypertension and vaso-occlusive complications"],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0b013e3283573a42","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}